Spis treści:
4. PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
| KOMISJA NADZORU FINANSOWEGO | ||||||||||||
| Raport bieżący nr | 3 | / | 2022 | |||||||||
| Data sporządzenia: | 2022-04-11 | |||||||||||
| Skrócona nazwa emitenta | ||||||||||||
| MILESTONE MEDICAL | ||||||||||||
| Temat | ||||||||||||
| Commencing Sales of CompuFlo Epidural / CathCheck Verification System Disposables to a Premier Northeast Hospital in the U.S. | ||||||||||||
| Podstawa prawna | ||||||||||||
| Art. 17 ust. 1 MAR - informacje poufne. | ||||||||||||
| Treść raportu: | ||||||||||||
| The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company", “the Issuer"), today announced that it has commenced sales of its CompuFlo® Epidural and CathCheck™ Verification System disposables to a leading northeast medical center in the U.S. The name of the hospital cannot be disclosed for confidentiality reasons. The Board of Directors of the Company is pleased to announce adoption of our CompuFlo Epidural and CathCheck Verification System by another leading medical center. This approval follows an extensive trial and evaluation, which validates the safety and efficacy of the technology. As a teaching hospital, the Company’s tools provide residents, fellows and seasoned physicians greater accuracy through real-time verification of epidural needle placement, as well as subsequent monitoring of catheter placement. With the addition of this hospital the Company continues to expand the national footprint in the labor and delivery market. |
||||||||||||
| MESSAGE (ENGLISH VERSION) | |||
INFORMACJE O PODMIOCIE >>>
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2022-04-11 | Keisha Harcum | Controller | Keisha Harcum | ||
Źródło:Komunikaty spółek (ESPI)
